BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 21464174)

  • 21. Intrathecal 5-methoxy-N,N-dimethyltryptamine in mice modulates 5-HT1 and 5-HT3 receptors.
    Alhaider AA; Hamon M; Wilcox GL
    Eur J Pharmacol; 1993 Nov; 249(2):151-60. PubMed ID: 7507056
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) used in a naturalistic group setting is associated with unintended improvements in depression and anxiety.
    Davis AK; So S; Lancelotta R; Barsuglia JP; Griffiths RR
    Am J Drug Alcohol Abuse; 2019; 45(2):161-169. PubMed ID: 30822141
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Qualitative and Quantitative Analysis of Tryptamines in the Poison of Incilius alvarius (Amphibia: Bufonidae).
    Schwelm HM; Zimmermann N; Scholl T; Penner J; Autret A; Auwärter V; Neukamm MA
    J Anal Toxicol; 2022 May; 46(5):540-548. PubMed ID: 33851996
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phase 1, placebo-controlled, single ascending dose trial to evaluate the safety, pharmacokinetics and effect on altered states of consciousness of intranasal BPL-003 (5-methoxy-
    Rucker JJ; Roberts C; Seynaeve M; Young AH; Suttle B; Yamamoto T; Ermakova AO; Dunbar F; Wiegand F
    J Psychopharmacol; 2024 Apr; ():2698811241246857. PubMed ID: 38616411
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of N,N-dimethyltryptamine in Humans.
    Good M; Joel Z; Benway T; Routledge C; Timmermann C; Erritzoe D; Weaver R; Allen G; Hughes C; Topping H; Bowman A; James E
    Eur J Drug Metab Pharmacokinet; 2023 May; 48(3):311-327. PubMed ID: 37086340
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular Docking, MM-GBSA, and Molecular Dynamics Approach: 5-MeO-DMT Analogues as Potential Antidepressants.
    Kalirajan R; Rishabh K; Srikanth J; Niharika M; Preeya N; Rezaul I
    Arch Razi Inst; 2023 Oct; 78(5):1603-1614. PubMed ID: 38590677
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Phase 1, Dose-Ranging Study to Assess Safety and Psychoactive Effects of a Vaporized 5-Methoxy-N, N-Dimethyltryptamine Formulation (GH001) in Healthy Volunteers.
    Reckweg J; Mason NL; van Leeuwen C; Toennes SW; Terwey TH; Ramaekers JG
    Front Pharmacol; 2021; 12():760671. PubMed ID: 34912222
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Schedules of controlled substances: placement of 5-methoxy-N,N-dimethyltryptamine into Schedule I of the Controlled Substances Act. Final rule.
    Drug Enforcement Administration (DEA), Department of Justice
    Fed Regist; 2010 Dec; 75(243):79296-300. PubMed ID: 21171485
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The natural hallucinogen 5-MeO-DMT, component of Ayahuasca, disrupts cortical function in rats: reversal by antipsychotic drugs.
    Riga MS; Soria G; Tudela R; Artigas F; Celada P
    Int J Neuropsychopharmacol; 2014 Aug; 17(8):1269-82. PubMed ID: 24650558
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacodynamic effects of serotonin (5-HT) receptor ligands in pigs: stimulation of 5-HT2 receptors induces malignant hyperthermia.
    Löscher W; Witte U; Fredow G; Ganter M; Bickhardt K
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Jun; 341(6):483-93. PubMed ID: 2118235
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 5-MeO-DMT modifies innate behaviors and promotes structural neural plasticity in mice.
    Jefferson SJ; Gregg I; Dibbs M; Liao C; Wu H; Davoudian PA; Woodburn SC; Wehrle PH; Sprouse JS; Sherwood AM; Kaye AP; Pittenger C; Kwan AC
    Neuropsychopharmacology; 2023 Aug; 48(9):1257-1266. PubMed ID: 37015972
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of Benefit Enhancement Strategies among 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) Users: Associations with Mystical, Challenging, and Enduring Effects.
    Lancelotta RL; Davis AK
    J Psychoactive Drugs; 2020; 52(3):273-281. PubMed ID: 32148190
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The serotonin hallucinogen 5-MeO-DMT alters cortico-thalamic activity in freely moving mice: Regionally-selective involvement of 5-HT
    Riga MS; Lladó-Pelfort L; Artigas F; Celada P
    Neuropharmacology; 2018 Nov; 142():219-230. PubMed ID: 29221792
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The roles of 5-HT1A and 5-HT2 receptors in the effects of 5-MeO-DMT on locomotor activity and prepulse inhibition in rats.
    Krebs-Thomson K; Ruiz EM; Masten V; Buell M; Geyer MA
    Psychopharmacology (Berl); 2006 Dec; 189(3):319-29. PubMed ID: 17013638
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Single Dose of 5-MeO-DMT Stimulates Cell Proliferation, Neuronal Survivability, Morphological and Functional Changes in Adult Mice Ventral Dentate Gyrus.
    Lima da Cruz RV; Moulin TC; Petiz LL; Leão RN
    Front Mol Neurosci; 2018; 11():312. PubMed ID: 30233313
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The potential of 5-methoxy-N,N-dimethyltryptamine in the treatment of alcohol use disorder: A first look at therapeutic mechanisms of action.
    Tap SC
    Addict Biol; 2024 Apr; 29(4):e13386. PubMed ID: 38600715
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distribution of the hallucinogens N,N-dimethyltryptamine and 5-methoxy-N,N-dimethyltryptamine in rat brain following intraperitoneal injection: application of a new solid-phase extraction LC-APcI-MS-MS-isotope dilution method.
    Barker SA; Littlefield-Chabaud MA; David C
    J Chromatogr B Biomed Sci Appl; 2001 Feb; 751(1):37-47. PubMed ID: 11232854
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A demand for clarity regarding a case report on the ingestion of 5-methoxy-N, N-dimethyltryptamine (5-MeO-DMT) in an Ayahuasca preparation.
    Callaway JC; Grob CS; McKenna DJ; Nichols DE; Shulgin A; Tupper KW
    J Anal Toxicol; 2006; 30(6):406-7; author reply 407. PubMed ID: 16872575
    [No Abstract]   [Full Text] [Related]  

  • 39. Infoveillance and Critical Analysis of the Systematically Reviewed Literature on Dimethyltryptamine and the "God Molecule".
    Al-Imam A; Motyka MA; Hoffmann B; Magowska A; Michalak M
    Pharmaceuticals (Basel); 2023 Jun; 16(6):. PubMed ID: 37375778
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 5-MeO-DMT for post-traumatic stress disorder: a real-world longitudinal case study.
    Ragnhildstveit A; Khan R; Seli P; Bass LC; August RJ; Kaiyo M; Barr N; Jackson LK; Gaffrey MS; Barsuglia JP; Averill LA
    Front Psychiatry; 2023; 14():1271152. PubMed ID: 38076677
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.